Physician

Navin K Jain, MD

According to 2025 Medicare claims, Navin Jain, MD (NPI: 1083611875) practices pulmonary disease in the Monroe, MI market, with the plurality of this provider's patient population coming from Monroe, MI. This provider's primary affiliated billing organization is PULMONARY N SLEEP SPECIALISTS PC (NPI: 1285381491; TIN: 880912918) and primary practice location at 48162-7815.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,405 traditional Medicare patients, billed 4,531 HCPCS/CPT codes, and received $318,549 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 6,180 prescription claims across 995 beneficiaries totaling $2,910,460 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 7,254 claims. Open Payments data shows 152 records totaling $3,023. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $589,414 to $318,549. Concurrently, Part D prescription costs have changed little. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$295K$589K2015 Medicare payment: $589,414 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $466,459 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $443,501 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $415,019 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $467,489 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $307,004 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $260,779 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $270,000 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $326,359 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $318,549 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,2668,932$589,414
20162,1877,125$466,459
20172,0697,009$443,501
20181,8136,636$415,019
20191,9427,244$467,489
20201,5464,490$307,004
20211,3803,698$260,779
20221,4344,030$270,000
20231,4584,674$326,359
20241,4054,531$318,549

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.5M$2.9M2015 Drug cost: $1,970,363 (USD; Tot_Drug_Cst)2016 Drug cost: $1,907,597 (USD; Tot_Drug_Cst)2017 Drug cost: $2,104,129 (USD; Tot_Drug_Cst)2018 Drug cost: $2,104,943 (USD; Tot_Drug_Cst)2019 Drug cost: $2,235,894 (USD; Tot_Drug_Cst)2020 Drug cost: $2,369,662 (USD; Tot_Drug_Cst)2021 Drug cost: $2,793,885 (USD; Tot_Drug_Cst)2022 Drug cost: $2,628,874 (USD; Tot_Drug_Cst)2023 Drug cost: $2,653,559 (USD; Tot_Drug_Cst)2024 Drug cost: $2,910,460 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20158846,415$1,970,363
20169637,318$1,907,597
20179937,607$2,104,129
20189907,434$2,104,943
20191,0167,154$2,235,894
20201,0077,374$2,369,662
20211,0216,792$2,793,885
20229626,126$2,628,874
20239375,709$2,653,559
20249956,180$2,910,460

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$288K$575K2015 Medicare payment: $492,314 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $425,256 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $375,087 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $461,613 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $559,972 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $575,450 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $505,994 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $443,469 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $502,238 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $380,584 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20153,3059,032$492,314
20163,8359,957$425,256
20174,05410,862$375,087
20184,37711,739$461,613
20194,94113,402$559,972
20204,26811,860$575,450
20213,95410,725$505,994
20223,2748,456$443,469
20233,1588,201$502,238
20242,7477,254$380,584

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99223Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes202245$131
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes213258$98
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more497815$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more449514$63
99232Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3611,351$60

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter69232,820$671,041
Sodium OxybateSodium Oxybate13390$248,389
XywavSodium,calcium,mag,pot Oxybate12360$237,382
Breztri AerosphereBudesonide/Glycopyr/Formoterol2288,550$176,077
Breo ElliptaFluticasone/Vilanterol27512,270$156,347

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R55$54,348
A7030Full face mask used with positive airway pressure device, eachN239575$53,426
A7031Face mask interface, replacement for full face mask, eachN232582$50,940
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY82591$38,961
A4604Tubing with integrated heating element for use with positive airway pressure deviceN292663$25,986

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.152$3,023AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Navin K. Jain, MD?

Tedicare shows public-source Medicare data for Navin K. Jain, MD (NPI 1083611875), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Navin K. Jain, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Navin K. Jain, MD?

Navin K. Jain, MD is linked to PULMONARY N SLEEP SPECIALISTS PC (billing NPI 1285381491) in the available physician profile data.

Does Navin K. Jain, MD have Open Payments data?

Navin K. Jain, MD has 152 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.